VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT-EHA CAR-T 2019 | The EMA’s PRIority MEdicines (PRIME) scheme

Here, Martina Schüßler-Lenz, MD European Medicines Agency, London, UK, gives insight on the EMA’s PRIority MEdicines (PRIME) scheme. Dr Schüßler-Lenz was speaking from the 1st European CAR T-Cell Meeting, held in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter